Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study

OBJECTIVE: To investigate the risk factors for the development of Pneumocystis jirovecii pneumonia (PCP) in patients with rheumatoid arthritis (RA) undergoing methotrexate (MTX) therapy. METHODS: This single-center retrospective cohort study included consecutive patients with RA who received MTX for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmura, Shin-ichiro, Homma, Yoichiro, Masui, Takayuki, Miyamoto, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038457/
https://www.ncbi.nlm.nih.gov/pubmed/34511571
http://dx.doi.org/10.2169/internalmedicine.8205-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038457/
https://www.ncbi.nlm.nih.gov/pubmed/34511571
http://dx.doi.org/10.2169/internalmedicine.8205-21

Ejemplares similares